Diagnostic criteria for amyotrophic lateral sclerosis
HC Timmins, AE Thompson… - Current Opinion in …, 2024 - journals.lww.com
The GCC are simpler to use than previous consensus criteria, with demonstrated greater
sensitivity and, enabling an earlier and more definitive ALS diagnosis, thereby facilitating …
sensitivity and, enabling an earlier and more definitive ALS diagnosis, thereby facilitating …
Urinary biomarkers for amyotrophic lateral sclerosis: candidates, opportunities and considerations
ML Rogers, DW Schultz, V Karnaros… - Brain …, 2023 - academic.oup.com
Amyotrophic lateral sclerosis is a relentless neurodegenerative disease that is mostly fatal
within 3–5 years and is diagnosed on evidence of progressive upper and lower motor …
within 3–5 years and is diagnosed on evidence of progressive upper and lower motor …
In silico exploration of metabolically active peptides as potential therapeutic agents against amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis (ALS) is regarded as a fatal neurodegenerative disease that is
featured by progressive damage of the upper and lower motor neurons. To date, over 45 …
featured by progressive damage of the upper and lower motor neurons. To date, over 45 …
[PDF][PDF] BRAIN COMMUNICATIONS
Encephalitis lethargica: clinical features and aetiology Page 1 BRAIN COMMUNICATIONS
https://doi.org/10.1093/braincomms/fcae347 BRAIN COMMUNICATIONS 2024: fcae347 | 1 …
https://doi.org/10.1093/braincomms/fcae347 BRAIN COMMUNICATIONS 2024: fcae347 | 1 …